Healthcare -
Biotechnology - NASDAQ - US
$ 2.89
-1.03 %
$ 1.75 B
Market Cap
-9.03
P/E
GERN - TOTAL EQUITY
Total Equity GERN - Geron Corporation
248 M
LAST VALUE
40.05%
2 YEAR CAGR
6.89%
5 YEAR CAGR
15.29%
10 YEAR CAGR